摘要
肺动脉高压是一种严重而无法治愈的肺血管疾病,其发病机制复杂。DNA甲基化是在甲基化转移酶的作用下调控基因选择性转录表达的表观遗传学修饰。近期研究发现,DNA甲基化在肺动脉高压的发生、发展过程中起着重要作用。该文就近年来对DNA甲基化影响肺动脉高压形成的研究作一综述。
Pulmonary arterial hypertension is a serious and incurable pulmonary vascular disease with complex pathogenesis.DNA methylation is an epigenetic modification that electively regulates the transcriptional expression of genes under the action of methyltransferase.Recent studies have demonstrated that DNA methylation plays a crucial role in the incidence and progression of pulmonary arterial hypertension.This review summarizes recent studies focusing upon the effect of DNA methylation on the incidence of pulmonary arterial hypertension.
作者
朱才民
李旎
孙乐波
郑大为
石活顺
徐国栋
邵国丰
Zhu Caimin;Li Ni;Sun Lebo;Zheng Dawei;Shi Huoshun;Xu Guodong;Shao Guofeng(Ningbo University Medical College,Ningbo 315211,China)
出处
《新医学》
2018年第4期230-233,共4页
Journal of New Medicine
基金
浙江省医药卫生科技平台项目(2017ZD026
2017RC026)
宁波市重大择优委托项目(2012C5017)
关键词
肺动脉高压
DNA甲基化
基因
表观遗传学
Pulmonary arterial hypertension
DNA methylation
Gene
Epigenetics